SEVERA v. SOLVAY SPECIALTY POLYMERS USA, LLC

CourtDistrict Court, D. New Jersey
DecidedMarch 10, 2021
Docket1:20-cv-06906
StatusUnknown

This text of SEVERA v. SOLVAY SPECIALTY POLYMERS USA, LLC (SEVERA v. SOLVAY SPECIALTY POLYMERS USA, LLC) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
SEVERA v. SOLVAY SPECIALTY POLYMERS USA, LLC, (D.N.J. 2021).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

KENNETH SEVERA, et al.

1:20-cv-06906-NLH-KMW Plaintiffs,

v.

OPINION SOLVAY SPECIALTY POLYMERS USA, LLC, et al.

Defendants.

APPEARANCES: DAVID M. CEDAR SHAUNA LAUREN FRIEDMAN ALAN HERSCHEL SKLARSKY WILLIAMS CEDAR, LLC 8 KINGS HIGHWAY WEST SUITE B HADDONFIELD, NJ 08033

On behalf of Plaintiffs

KEGAN ANDREW BROWN LATHAM & WATKINS LLP 885 3RD AVENUE NEW YORK, NY 10022

On behalf of Defendant Solvay Specialty Polymers USA, LLC, successor by merger to Solvay Solexis, Inc.

JOHN D. NORTH IRENE HSIEH JEMI GOULIAN LUCEY MARJAN MOUSSAVIAN GREENBAUM, ROWE, SMITH & DAVIS, LLP 99 WOOD AVENUE SOUTH ISELIN, NJ 08830 KHRISTOPH ANDREAS BECKER STEPTOE & JOHNSON LLP 1114 AVENUE OF THE AMERICAS 35TH FLOOR NEW YORK, NY 10036

ROBERT L. SHUFTAN (pro hac vice) STEPTOE & JOHNSON LLP 227 WEST MONROE STREET SUITE 4700 CHICAGO, IL 60606

JOO CHA WEBB (pro hac vice) STEPTOE & JOHNSON LLP 633 WEST FIFTH STREET SUITE 1900 LOS ANGELES, CA 90071

On behalf of Defendant Arkema, Inc.

HILLMAN, District Judge In this putative class action, Plaintiffs1 assert claims against Defendants for damages arising from Defendants’ alleged contamination of the municipal water supply in National Park, New Jersey with poly- and perfluoroalkyl substances (“PFAS”), particularly perflouoronaonanoic acid (“PFNA”) and perfluorooctanoic acid (“PFOA”). Presently before the Court are the motions of Defendants to dismiss Plaintiffs’ claims. For the reasons expressed below, Defendants’ motions will be granted on one issue, but denied in all other respects.

1 There are seven named Plaintiffs who all reside in National Park, New Jersey: Kenneth Severa, Carol Binck, Edward Lastowka, Suzette Lastowka, William Teti, Denise Snyder, and Jennifer Stanton. BACKGROUND Plaintiffs’ amended complaint (Docket No. 6) claims that Defendants, Solvay Specialty Polymers USA, LLC and its predecessor Solvay Solexis, Inc., and Arkema, Inc., discharged or were responsible for contamination of PFAS, particularly PFNA and PFOA, into the air, water and groundwater from their facility in West Deptford, New Jersey.2 Plaintiffs claim that over time, widespread PFNA and PFOA contamination has been discovered in the potable well water of residents in southern New Jersey who reside near this facility, as well as in municipal water wells, such as Plaintiffs’ municipal water in National Park, at levels that threaten the health of those exposed and which create a public

and private nuisance. Plaintiffs claim that these chemicals are persistent in the environment, hazardous, and are not known to ever break down in water, soil, air, or the human body. Plaintiffs claim that Defendants’ improper disposal consisted, in part, of dumping the PFNA and other PFAS into the sewer system – a process which Defendants knew or should have known would result in the discharge of the PFNA and other PFAS

2 Solvay operates a plant located at 10 Leonard Lane, West Deptford, New Jersey 08086, which encompasses 243 acres. Arkema is the corporate successor to the entities, Pennwalt and Elf, that owned and operated the plant until 1990. The plant was sold to Ausimont USA in 1990, and in 2002 Solvay acquired Ausimont. into the environment. Plaintiffs further claim that Defendants also discharged these chemicals directly into the environment, where they are subject to atmospheric dispersion and eventual deposition associated with the prevailing wind patterns. This dispersion and deposition results in human exposure both on-site and off-site of the plant. More specifically, Plaintiffs claim that Defendants improperly disposed of PFNA, PFOA and other PFAS on the actual plant site, contaminating the groundwater immediately beneath the plant, which is the source of the water used by the National Park Water Department for its drinking water, and that the PFNA used and discharged at the plant by Defendants from 1988 to 2010 have been detected in high

concentrations in the drinking water for National Park. Plaintiffs’ amended complaint relates that PFNA and other PFAS are associated with increased risk in humans of testicular cancer, kidney cancer, prostate cancer, non-Hodgkin’s lymphoma, pancreatic and ovarian cancer, as well as thyroid disease, high cholesterol, high uric acid levels, elevated liver enzymes, ulcerative colitis, and pregnancy-induced hypertension, as well as other conditions. Exposure may result in developmental effects to fetuses during pregnancy or to breastfed infants, liver damage, and various immunological effects. PFNA and other PFAS persist and bioaccumulate in humans, and as a result, comparatively low exposures such as those suffered by Plaintiffs may result in large body burdens persisting for years. Plaintiffs claim that there is a causal link between exposure to PFNA, and other PFAS, and subclinical or subcellular injury and serious latent human disease. Plaintiffs’ amended complaint states that in 2018, New Jersey set the Maximum Contaminant Level (“MCL”) for PFNA at 13 ppt, and the New Jersey Department of Environmental Protection (“NJDEP”) required water utilities to begin testing for PFNA in their water beginning in the first quarter of 2019. Since an effective date of January 22, 2020, National Park has been subject to an enforcement action by NJDEP for violating the MCL

for PFNA in samples taken from its treatment plant. According to NJDEP, samples taken from the National Park Water Department treatment plant exceeded the MCL of 13 parts per trillion for the time periods October 1, 2019 through December 31, 2019, and January 1, 2020 through March 31, 2020, in violation of N.J.A.C. 7:10-5.5(2)a5. Since at least April 2019, and each quarter thereafter continuing to today, National Park Water Department has notified its customers that its water is contaminated with PFNA at levels above the MCL. Although Plaintiffs and the proposed classes were not made aware that their drinking water was contaminated by PFNA until 2019, the existence of the contamination extends much further back in time. Data provided to NJDEP about PFA use at the West Deptford plant indicate that 86.6% of the 125,069 kg of Surflon S-111 PFA mixture (which is primarily PFNA) used between 1991 and 2010 was released into the environment (i.e., the surrounding air and water). There are approximately 1,000 households and approximately 3,000 residents in National Park. All or nearly all of the residents of National Park rely on the National Park Water Department for the provision of water and sewer services, and there are no households in National Park that draw drinking water from private wells. National Park Water Department has

advised its customers to purchase NSF-certified carbon filtration systems at their own cost. Plaintiffs’ amended complaint asserts six counts against Defendants: Count I - Public Nuisance, Count II - Private Nuisance, Count III - Trespass, Count IV - Negligence, Count V - New Jersey Spill Compensation and Control Act (“Spill Act”), N.J.S.A. 58:10-23.11 et seq., and Count VI - Punitive Damages. Plaintiffs have also asserted putative class action claims pursuant to Federal Rules of Civil Procedure 23(a), 23(b)(2), and (b)(3). Plaintiffs propose three classes: Municipal Water Property Damage Class, Municipal Water Nuisance Class, and Biomonitoring Class.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Scheuer v. Rhodes
416 U.S. 232 (Supreme Court, 1974)
Papasan v. Allain
478 U.S. 265 (Supreme Court, 1986)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Sprint Communications Co. v. APCC Services, Inc.
554 U.S. 269 (Supreme Court, 2008)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Karen Malleus v. John George
641 F.3d 560 (Third Circuit, 2011)
Evancho v. Fisher
423 F.3d 347 (Third Circuit, 2005)
Common Cause of Pennsylvania v. Pennsylvania
558 F.3d 249 (Third Circuit, 2009)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Perez v. Wyeth Laboratories Inc.
734 A.2d 1245 (Supreme Court of New Jersey, 1999)
VEGA BY MUNIZ v. Piedilato
713 A.2d 442 (Supreme Court of New Jersey, 1998)
In Re Lead Paint Litigation
924 A.2d 484 (Supreme Court of New Jersey, 2007)
Cresskill Borough v. Dumont Borough
100 A.2d 182 (New Jersey Superior Court App Division, 1953)

Cite This Page — Counsel Stack

Bluebook (online)
SEVERA v. SOLVAY SPECIALTY POLYMERS USA, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/severa-v-solvay-specialty-polymers-usa-llc-njd-2021.